المؤلفون: Ramon Arntz, Serena Martelli, R. Gutzmer, Nicholas Squittieri, Dirk Schadendorf, Caroline Robert, Carmen Loquai, Reinhard Dummer

المساهمون: University of Zurich, Gutzmer, Ralf

المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer

مصطلحات موضوعية: Adult, Cancer Research, Skin Neoplasms, Pyridines, medicine.medical_treatment, Medizin, Tumor outcome, Vismodegib, 610 Medicine & health, mRECIST, Drug Administration Schedule, Hedgehog pathway inhibitor, Sonidegib, chemistry.chemical_compound, Double-Blind Method, 1311 Genetics, Confidence Intervals, Genetics, Humans, Medicine, Anilides, Basal cell carcinoma, 1306 Cancer Research, Response Evaluation Criteria in Solid Tumors, RC254-282, medicine.diagnostic_test, business.industry, Research, Biphenyl Compounds, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 10177 Dermatology Clinic, Magnetic resonance imaging, medicine.disease, Confidence interval, Radiation therapy, Treatment Outcome, chemistry, Oncology, Carcinoma, Basal Cell, Disease Progression, 2730 Oncology, business, Nuclear medicine, Progressive disease, medicine.drug

وصف الملف: 924_Gutzmer_R._et_al._Assessment_of_various_efficacy_outcomes_using_ERIVANCE-like_criteria_in_patients_with_locally_advanced_basal_cell_carcinoma_receiving_sonidegib_BMC_Cancer_2021.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db8d273e34be76c08b02bf466b6db805Test
https://doi.org/10.5167/uzh-210585Test

المؤلفون: Paolo A. Ascierto, Dirk Schadendorf, Selma Ugurel, Alexander M.M. Eggermont, Reinhardt Dummer, Elisabeth Livingstone, Lisa Zimmer, Anne Zaremba, Georgina V. Long, Caroline Robert

المساهمون: University of Zurich, Schadendorf, Dirk

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cancer Research, medicine.medical_treatment, Medizin, 610 Medicine & health, Pembrolizumab, Targeted therapy, chemistry.chemical_compound, Internal medicine, medicine, Humans, 1306 Cancer Research, Immune Checkpoint Inhibitors, Melanoma, Entinostat, business.industry, 10177 Dermatology Clinic, Immune checkpoint, Clinical trial, chemistry, 2730 Oncology, Immunotherapy, Nivolumab, business, Lenvatinib, Adjuvant

وصف الملف: 906_Zaremba_A._et_al._The_concepts_of_rechallange_and_retreatment_with_immune_checkpoints_blockade_in_melanoma_patients_EJC_2021.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af59f477caa0569ca2410181854e889Test
https://www.zora.uzh.ch/id/eprint/206131Test/

المؤلفون: Paolo A. Ascierto, Dirk Schadendorf, Reinhard Dummer, Caroline Robert, Paul Nathan

مصطلحات موضوعية: Oncology, Proto-Oncogene Proteins B-raf, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Metastatic melanoma, Immune checkpoint inhibitors, medicine.medical_treatment, Medizin, Context (language use), Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Immune system, Internal medicine, medicine, Tumor Microenvironment, Humans, 030212 general & internal medicine, Molecular Targeted Therapy, Immune Checkpoint Inhibitors, Melanoma, Tumor microenvironment, business.industry, medicine.disease, Clinical trial, 030220 oncology & carcinogenesis, Immunotherapy, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f1ca59ce0a443693aed8c8e11018ab9Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85092193946Test

المؤلفون: Dirk Schadendorf, Caroline Dutriaux, Caroline Robert, Reinhard Dummer, John M. Kirkwood, Marta Nyakas, Mario Mandalà, Laurent Mortier, Axel Hauschild, Kohinoor Dasgupta, Monique Tan, Eduard Gasal, James Larkin, Jacob Schachter, Vanna Chiarion Sileni, Andrew Haydon, Victoria Atkinson, Mario Santinami, Georgina V. Long

مصطلحات موضوعية: Oncology, Trametinib, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Melanoma, Mutant, Medizin, Dabrafenib, Placebo, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, In patient, Stage (cooking), business, Adjuvant, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f486f97df79593e3e9abb490624153c0Test

المؤلفون: Aisha Masood, Keith T. Flaherty, Reinhard Dummer, Erika Richtig, Hussein Abdul-Hassan Tawbi, Céleste Lebbé, Neha Pakhle, Caroline Robert, Paul Nathan, Naoya Yamazaki, Mario Mandalà, Dirk Schadendorf, Victoria Atkinson, Paolo A. Ascierto, Ana Arance, Antoni Ribas, Georgina V. Long, Eduard Gasal

مصطلحات موضوعية: Trametinib, Cancer Research, business.industry, Melanoma, medicine.medical_treatment, Anti pd 1, Mutant, Medizin, Dabrafenib, medicine.disease, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Cancer research, Medicine, In patient, business, 030215 immunology, medicine.drug, Advanced melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75c8d57ccfac94d27b8372d465da2a0Test

المؤلفون: Caroline Robert, Jacob Schachter, Thierry Lesimple, C. Dutriaux, Dirk Schadendorf, Monique Tan, Axel Hauschild, Georgina V. Long, R. Dummer, Eduard Gasal, Mario Santinami, Kohinoor Dasgupta, James Larkin, Mario Mandalà, Andrew M. Haydon, John M. Kirkwood, Vanna Chiarion Sileni, Laurent Mortier, Victoria Atkinson, Marta Nyakas, Ruth Plummer

المساهمون: University of Zurich

مصطلحات موضوعية: Male, Oncology, Skin Neoplasms, medicine.medical_treatment, Medizin, Administration, Oral, 2700 General Medicine, 030204 cardiovascular system & hematology, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Oximes, Medicine, 030212 general & internal medicine, Neoplasm Metastasis, Melanoma, Trametinib, Imidazoles, Follow up studies, 10177 Dermatology Clinic, General Medicine, Middle Aged, Female, Adjuvant, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Pyridones, 610 Medicine & health, Pyrimidinones, Disease-Free Survival, 03 medical and health sciences, Adjuvants, Immunologic, Double-Blind Method, Internal medicine, Humans, Stage III melanoma, Protein Kinase Inhibitors, Survival analysis, Aged, Neoplasm Staging, business.industry, Dabrafenib, Survival Analysis, Clinical trial, Mutation, business, Follow-Up Studies

وصف الملف: 848_Dummer_R._et_al._Five-Year_Analysis_of_Adjuvant_Dabrafenib_plus_Trametinib_in_Stage_III_Melanoma_NEJM_2020.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d710d2b0f671e5dafc838391b9965d4aTest
https://www.zora.uzh.ch/id/eprint/190018Test

المؤلفون: Jacob Schachter, Dirk Schadendorf, Eduard Gasal, Laurent Mortier, Marta Nyakas, Egbert de Jong, Caroline Dutriaux, Reinhard Dummer, Mario Santinami, Georgina V. Long, John M. Kirkwood, Mario Mandalà, Victoria Atkinson, Vanna Chiarion-Sileni, Andrew Haydon, Caroline Robert, Christine-Elke Ortmann, James Larkin, Richard F. Kefford, Axel Hauschild

مصطلحات موضوعية: Trametinib, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Mutant, Hazard ratio, Medizin, Dabrafenib, Placebo, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Internal medicine, medicine, In patient, Stage III melanoma, business, Adjuvant, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f42511b4b46cd8c4fde9d100d74a0872Test

المؤلفون: Victoria Atkinson, Andrew Haydon, Caroline Robert, John M. Kirkwood, Jan C. Brase, Mario Mandalà, Marta Nyakas, James Garrett, James Larkin, Richard F. Kefford, Caroline Dutriaux, Reinhard Dummer, Axel Hauschild, Catarina D. Campbell, Bijoyesh Mookerjee, Dirk Schadendorf, Vanna Chiarion-Sileni, Paola Aimone, Georgina V. Long, Mario Santinami

مصطلحات موضوعية: Trametinib, Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Medizin, Dabrafenib, Placebo, Gene expression profiling, Internal medicine, medicine, In patient, Stage (cooking), business, Adjuvant, Immune gene, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92ad03e7f7c5e730efb55c2b885bece4Test

المؤلفون: Christian U. Blank, Adil Daud, Rene Gonzalez, Kim Margolin, Scot Ebbinghaus, Ziwen Wei, Dirk Schadendorf, Antoni Ribas, Anna C. Pavlick, Lee D. Cranmer, Caroline Robert, April K.S. Salama, Jacob Schachter, Omid Hamid, Reinhard Dummer, Nageatte Ibrahim, F. Stephen Hodi, Igor Puzanov, Tara C. Gangadhar, Paolo A. Ascierto

المساهمون: University of Zurich, Hamid, Omid

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Skin Neoplasms, Time Factors, medicine.medical_treatment, Medizin, Phases of clinical research, Pembrolizumab, Kaplan-Meier Estimate, 0302 clinical medicine, Antineoplastic Agents, Immunological, 1306 Cancer Research, Melanoma, Aged, 80 and over, education.field_of_study, Cross-Over Studies, Drug Substitution, Hazard ratio, 10177 Dermatology Clinic, Middle Aged, MAP Kinase Kinase Kinases, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, 2730 Oncology, Female, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Adolescent, Population, Ipilimumab, 610 Medicine & health, Antibodies, Monoclonal, Humanized, Disease-Free Survival, 03 medical and health sciences, Young Adult, Internal medicine, medicine, Humans, education, Protein Kinase Inhibitors, Aged, Chemotherapy, business.industry, medicine.disease, Confidence interval, Surgery, 030104 developmental biology, Drug Resistance, Neoplasm, Mutation, business

وصف الملف: 721_Hamid_O._et_al._Final_analysis_of_randomised_trial_comparing_pembrolizumab_versus_Eur_J_Cancer_2017.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab24a3779538f584d0432f320113cbb5Test
https://www.ncbi.nlm.nih.gov/pubmed/28961465Test

المؤلفون: Nageatte Ibrahim, Christian U. Blank, Igor Puzanov, Ricardo J. Gonzalez, Jacob Schachter, April K.S. Salama, Lee D. Cranmer, Omid Hamid, Tara C. Gangadhar, Caroline Robert, Z. Wei, Paolo A. Ascierto, Antoni Ribas, Reinhard Dummer, F.S. Hodi, Scot Ebbinghaus, Anna C. Pavlick, Dirk Schadendorf, Adil Daud, Kim Margolin

مصطلحات موضوعية: 0301 basic medicine, Oncology, Chemotherapy, medicine.medical_specialty, business.industry, Melanoma, medicine.medical_treatment, Medizin, Ipilimumab, Hematology, Pembrolizumab, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Refractory, 030220 oncology & carcinogenesis, Internal medicine, Overall survival, Medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b62276f800d91eb66c90495e2d7fa0dTest